3 Top Biotech Stocks to Buy Right Now
There's good reason to consider buying shares in these biotech companies soon.
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Key Data Points
Primary metrics and data points about Arena Pharmaceuticals.| Current Price: | $39.69 |
| Prev Close: | $39.27 |
| Open: | $39.39 |
| Bid: | $39.01 |
| Ask: | $39.79 |
| Day's Range: | $38.82 - $39.82 |
| 52wk Range: | $11.30 - $45.85 |
| Volume: | 719,917 |
| Avg Vol | 2,207,725 |
| Market Cap: | $2B |
| P/E (ttm): | -13.68 |
| EPS (ttm): | ($2.87) |
| Div & Yield: | $0.00 (0.0%) |
Company Rating
What our community thinks about Arena Pharmaceuticals.
CAPS Rating
CAPS All Stars
Powered by 
CEO Rating
The single most important factor in a company's success is the team that's leading the company.Amit Munshi, CEO
90% Approve
Based on 7 Ratings
Business Summary
Industry, sector and description for Arena Pharmaceuticals.A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Drug Makers